Oesophageal varices as an initial manifestation of JAK2-positive myeloproliferative neoplasms

被引：0
|
作者：
Link, C. [1 ]
Platzbecker, U. [1 ]
Brueckner, S. [1 ]
Thiede, C. [1 ]
Ehninger, G. [1 ]
Schuler, M. [1 ]
机构：
[1] Univ Klinikum Dresden, Med Klin 1, Dresden, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [11] Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α
    Riley, Caroline H.
    Hansen, Morten
    Brimnes, Marie K.
    Hasselbalch, Hans C.
    Bjerrum, Ole W.
    Straten, Per Thor
    Svane, Inge Marie
    Jensen, Morten Krogh
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (03) : 227 - 234
  • [12] Assessing the Feasibility of Thromboprophylaxis with Apixaban in JAK2-Positive Myeloproliferative Neoplasm Patients: The Airport-MPN Trial
    Kimpton, Miriam
    Cerquozzi, Sonia
    Toupin, Dominique
    Villeneuve, Pierre
    Siegal, Deborah
    Carrier, Marc
    Delluc, Aurelien
    BLOOD, 2023, 142
  • [13] Portal vein thrombosis as the presenting manifestation of JAK2 positive myeloproliferative neoplasm
    Jeon, Won Jin
    Mehta, Akhil
    Hudson, Jessica
    Castillo, Dani Ran
    Wang, Jun
    Nguyen, Anthony
    Akhtari, Mojtaba
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 (05): : 457 - 461
  • [14] Clinical outcomes of patients with JAK2, CALR and MPL positive myeloproliferative neoplasms
    Komic, H.
    Islamagic, E.
    Kurtovic, S.
    Burekovic, A.
    Uzunovic, A.
    Kurtovic-Kozaric, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1841 - 1842
  • [15] A Rare Coexistence of Smoldering Multiple Myeloma and JAK2-Positive Myeloproliferative Neoplasm: A Case of Dual Synchronous Hematological Malignancy
    Hammani, Adnane
    Doghmi, Othman
    Allaoui, Mohammed
    Ababou, Mounir
    Mahtat, El Mehdi
    El Maaroufi, Hicham
    Doghmi, Kamal
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [16] MK-0457 is a novel aurora kinase and janus kinase 2 (JAK2) inhibitor with activity in transformed JAK2-Positive myeloproliferative disease (MPD).
    Giles, Francis
    Bergstrom, Donald A.
    Garcia-Manero, Guillermo
    Kornblau, Steven
    Andreeff, Michael
    Kantarjan, Hagop
    Jones, Dan
    Freedman, Steven J.
    Verstovsek, Srdan
    BLOOD, 2006, 108 (11) : 309B - 310B
  • [17] Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis
    Marte Karen Brattås
    Kyrre Lilleeng
    Randi Hovland
    Ingvild Jenssen Lægreid
    Marta Vorland
    Friedemann Leh
    Øystein Bruserud
    Bjørn Tore Gjertsen
    Håkon Reikvam
    Biomarker Research, 6
  • [18] Concurrent JAK2-Positive Myeloproliferative Disorder and Chronic Myelogenous Leukemia: A Novel Entity? A Case Report With Review of the Literature
    Bader, Gilbert
    Dreiling, Bernard
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2019, 7
  • [19] A CASE OF JAK2-POSITIVE ESSENTIAL THROMBOCYTOSIS WITH VASOMOTOR SYMPTOMS
    Chiang, Melissa
    Shah, Divya
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S575 - S575
  • [20] JAK2 and MPL mutations in myeloproliferative neoplasms
    Koppikar, Priya
    Levine, Ross L.
    ACTA HAEMATOLOGICA, 2008, 119 (04) : 218 - 225
12345